Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma

Hepatology Research

Volumn 41, Issue 8, 2011, Pages 738-745

  Shirai, Kiyokazu ^a   Tamai, Hideyuki ^a   Shingaki, Naoki ^a   Mori, Yoshiyuki ^a   Moribata, Kosaku ^a   Enomoto, Shotaro ^a   Deguchi, Hisanobu ^a   Ueda, Kazuki ^a   Maekita, Takao ^a   Inoue, Izumi ^a   Iguchi, Mikitaka ^a   Yanaoka, Kimihiko ^a   Oka, Masashi ^a   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Seeding

Indexed keywords

DECARBOXYPROTHROMBIN;

AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RISK FACTOR; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR ABLATION; TUMOR BIOPSY; TUMOR SEEDING;

EID: 79960709833     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00841.x     Document Type: Article

References (22)

1. Arii S, Teramoto K, Kawamura T etal. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg 2001; 8: 397-403.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
3. Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update. Hepatol Res 2010; 40 (Suppl 1): 2-144.
4. Rossi S, Di Stasi M, Buscarini E etal. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167: 759-68.
5. Tateishi R, Shiina S, Teratani T etal. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-9.
6. Shiina S, Teratani T, Obi S etal. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-30.
7. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-6.
8. Mulier S, Mulier P, Ni Y etal. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89: 1206-22.
9. de Baere T, Risse O, Kuoch V etal. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181: 695-700.
10. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-51.
11. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer 1954; 7: 462-503.
12. Uehara T, Hirooka M, Ishida K etal. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol 2007; 42: 306-11.
13. Llovet JM, Vilana R, Bru C etal. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-9.
14. Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-8.
15. Jaskolka JD, Asch MR, Kachura JR etal. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol 2005; 16: 485-91.
16. Imamura J, Tateishi R, Shiina S etal. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008; 103: 3057-62.
17. Theise ND. Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations. Semin Liver Dis 1995; 15: 360-71.
18. Silva MA, Hegab B, Hyde C, Guo B, Buckels JA, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 2008; 57: 1592-6.
19. Tung WC, Huang YJ, Leung SW etal. Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy. Liver Int 2007; 27: 192-200.
20. Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007; 33: 437-47.
21. Kotoh K, Morizono S, Kohjima M, Enjoji M, Sakai H, Nakamuta M. Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model. Liver Int 2005; 25: 1217-23.
22. Kotoh K, Nakamuta M, Morizono S etal. A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time. Liver Int 2005; 25: 542-7.